Just a moment...
Press 'Enter' to add multiple search terms. Rules for Better Search
Use comma for multiple locations.
---------------- For section wise search only -----------------
Accuracy Level ~ 90%
Press 'Enter' after typing page number.
Press 'Enter' after typing page number.
No Folders have been created
Are you sure you want to delete "My most important" ?
NOTE:
Press 'Enter' after typing page number.
Press 'Enter' after typing page number.
Don't have an account? Register Here
Press 'Enter' after typing page number.
Issues: Whether physician samples cleared free of cost are to be valued under Rule 4 read with Rule 11 of the Central Excise Valuation (Determination of Price of Excisable Goods) Rules, 2000, and whether the duty demand on such samples was sustainable.
Analysis: Physician samples were not sold and had no transaction value, so valuation could not be made under Section 4(1)(a) of the Central Excise Act, 1944. The goods were identical in material characteristics to the medicines sold in the market, save for packing and quantity variations, making comparable sale value the appropriate benchmark. Rule 4, being the general valuation rule for goods not sold at the time and place of removal, was held applicable, and where necessary its application could be supported by Rule 11 as a reasonable method consistent with the rules. Rule 8 was inapplicable because the samples were not captively consumed in the manufacture of other articles. Section 4A was also inapplicable because the samples were not MRP-based goods. The settled approach from the earlier decision concerning physician samples was followed.
Conclusion: The demand on clearance of physician samples was upheld and the valuation under Rule 4 read with Rule 11 was sustained.